Cargando…

New Devices in Glaucoma

Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm’s canal, and suprachoroidal space, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Lilian, Moster, Marlene R., Bicket, Amanda K., Sheybani, Arsham, Sarkisian, Steven R., Samuelson, Thomas W., Ahmed, Iqbal Ike K., Miller-Ellis, Eydie, Smith, Oluwatosin U., Cui, Qi N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441989/
https://www.ncbi.nlm.nih.gov/pubmed/37558818
http://dx.doi.org/10.1007/s40123-023-00780-3
Descripción
Sumario:Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm’s canal, and suprachoroidal space, sustained-release drug delivery devices, and extraocular devices aiming to reduce glaucomatous progression through other novel means. In this review, we provide an overview of several novel devices either newly available or in development for the medical and surgical management of glaucoma. Further studies are required to determine the long-term efficacy of these devices and how they will integrate into the current landscape of glaucoma management.